Resolutions General Meeting of Shareholders ForFarmers N.V.

11 April 2024 - 12:32

During the General Meeting of Shareholders of ForFarmers N.V. (hereinafter referred to as the 'General Meeting' and 'ForFarmers' respectively), held today, the shareholders adopted the financial statements for the 2023 financial year and also approved the dividend proposal for the said financial year. 

The dividend of € 0,15 per ordinary share will be paid to ForFarmers' shareholders entirely in cash, after deducting 15% dividend withholding tax. The ex-dividend date is 15 April 2024 and and the dividend will be paid on April 24, 2024.

Other resolutions

  • An advisory vote was cast in favour of the 2023 remuneration report (for 97,2 %; against 2,8%).
  • Discharge was granted to each member of the Executive Board and Mr. R.J. Tjebbes for the performance of their duties during the 2023 financial year.
  • Discharge was granted to each member of the Supervisory Board for the performance of his/her duties during the 2023 financial year.
  • KPMG Accountants N.V. has been appointed as auditor of ForFarmers to audit the 2024 financial statements and executive board report.
  • Ms. A. den Otter was reappointed as a member of the Supervisory Board.
  • The Executive Board has been designated as the authorised body - subject to the approval of the Supervisory Board - to issue ordinary shares and to grant rights to subscribe for ordinary shares limited to 10% of the issued ordinary shares for a period of 18 months.
  • The Executive Board has been designated as the authorised body - subject to the approval of the Supervisory Board - to limit or exclude shareholders' pre-emptive rights for a period of 18 months.
  • Authorisation was granted to the Executive Board - subject to the approval of the Supervisory Board – to have ForFarmers acquire (other than without consideration) shares in its own share capital (irrespective of the type) up to a maximum of 10% of the issued share capital of ForFarmers (determined at the time of the General Meeting). This authorisation provides the necessary flexibility to, among other things, optimise the capital structure and/or to fulfil obligations regarding (depositary receipts for) share-related incentive schemes.